1.07Open0.02Pre Close1 Volume19 Open Interest129.00Strike Price107.00Turnover370.35%IV23.02%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry1.07Extrinsic Value100Contract SizeAmericanOptions Type0.0042Delta0.0016Gamma98.81Leverage Ratio-0.2843Theta0.0000Rho0.42Eff Leverage0.0003Vega
Novo-Nordisk A/S Stock Discussion
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...
The agreement The acquisition of the three production sites was announced on February 5. On May 29, Catalent shareholders voted in favor of the pending transac...
$Novo-Nordisk A/S (NVO.US)$
new
for some reason the profile says its lly
it's so greeen
Add...
No comment yet